Gritstone Bio Long Term Debt

Gritstone Bio (GRTS) currently reports a long-term debt of $41M as of June 2024. That compares with $91M in the prior-year period — down 55.3% year over year. Use the charts on this page to explore Gritstone Bio's long-term debt history and peer comparisons.

Gritstone Bio's long-term debt decreased from $91M to $41M — a 55.3% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Gritstone Bio reported $41M in long-term debt as of June 2024. That compares with $91M in the prior-year period — down 55.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $41M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Gritstone Bio, and consider following GRTS for alerts when major investors trade the stock.

Gritstone Bio is classified in the Healthcare sector. On long-term debt, it currently shows $41M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GRTS with unrelated industries.